https://www.selleckchem.com/pr....oducts/isoxazole-9-i
igh completion rate, and minimal time commitment. It was an effective electronic reporting mechanism for patients, enabling the medical team to develop specific strategies for alleviating bothersome symptoms during follow-up. Current understanding of the causes of treatment failure in is poor and antimicrobial susceptibility data are lacking. We used genome sequencing to seek evidence of antimicrobial resistance in isolates sourced from patients who were persistently infected. Genomic DNA was extracted from isolates cultured i